|
|
Article: Other News To Note.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
o Aethlon Medical Inc., of San Diego, said researchers have discovered the Aethlon Hemopurifier is effective in capturing particles that suppress the immune response in cancer patients. The particles, known as exosomes, are released by solid tumors, lymphomas and leukemia. Exosomes induce T-cell apoptosis and block T-cell signaling, proliferation and cytokine production. High concentrations of circulating exosomes correlate with reduced T-cell production and tumor progression in cancer patients. In studies, 60 percent of circulating exosomes were removed from the blood of ovarian cancer patients during first pass (approximately 10-minutes) through a small-scale ...